logo

Quince Therapeutics Inc (QNCX) Stock: 52-Week Performance Insights and Trading Volume

SLGG

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Quince Therapeutics Inc’s current trading price is -53.76% away from its 52-week high, while its distance from the 52-week low is 121.46%. The stock’s price range over this period has fluctuated between $0.51 and $2.45. The company, operating within the financial sector, had a trading volume of approximately 0.54 million for the day, which was noticeably higher than the average daily share volume of 0.12 million over the last 3 months.

In terms of market performance, Quince Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $2.45 on 12/09/24, and the lowest value was recorded at $0.51 on 08/15/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Quince Therapeutics Inc (QNCX) has experienced a quarterly decline of -34.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 49.95M and boasts a workforce of 36 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5304, with a change in price of -0.9170. Similarly, Quince Therapeutics Inc recorded 147,259 in trading volume during the last 100 days, posting a change of -44.73%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for QNCX stands at 0.49. Similarly, the long-term debt-to-equity ratio is also 0.49.

QNCX Stock Stochastic Average

Today’s raw stochastic average for Quince Therapeutics Inc over the last 50 days is 30.03%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 45.90%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 49.27% and 40.66%, respectively.

QNCX Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -39.41%.However, over the last six months, we can see a weaker performance of 30.23%. Over the last 30 days, the price of QNCX has leaped by -19.07%. And in the last five days, it has surged by 7.90%.

Most Popular